These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31380290)

  • 1. Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC.
    Liu X; Zhang M; Liu X; Sun H; Guo Z; Tang X; Wang Z; Li J; Li H; Sun W; Zhang Y
    Front Oncol; 2019; 9():663. PubMed ID: 31380290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot investigation of a urinary metabolic biomarker discovery in renal cell carcinoma.
    Zhang M; Liu X; Liu X; Li H; Sun W; Zhang Y
    Int Urol Nephrol; 2020 Mar; 52(3):437-446. PubMed ID: 31732842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell Carcinoma.
    Falegan OS; Ball MW; Shaykhutdinov RA; Pieroraio PM; Farshidfar F; Vogel HJ; Allaf ME; Hyndman ME
    Metabolites; 2017 Feb; 7(1):. PubMed ID: 28165361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma.
    Liu X; Zhang M; Cheng X; Liu X; Sun H; Guo Z; Li J; Tang X; Wang Z; Sun W; Zhang Y; Ji Z
    Front Oncol; 2020; 10():717. PubMed ID: 32500026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on potential markers for diagnosis of renal cell carcinoma by serum untargeted metabolomics based on UPLC-MS/MS.
    Wang J; Yang WY; Li XH; Xu B; Yang YW; Zhang B; Dai CM; Feng JF
    Front Physiol; 2022; 13():996248. PubMed ID: 36523562
    [No Abstract]   [Full Text] [Related]  

  • 7. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma.
    Sato T; Kawasaki Y; Maekawa M; Takasaki S; Saigusa D; Ota H; Shimada S; Yamashita S; Mitsuzuka K; Yamaguchi H; Ito A; Kinoshita K; Koshiba S; Mano N; Arai Y
    Int J Cancer; 2019 Jul; 145(2):484-493. PubMed ID: 30628065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Solmoirago MJ; Sánchez-González JV; Vera-Donoso CD; Martínez-Sarmiento M; España F; Navarro S; Medina P
    J Proteomics; 2020 Apr; 218():103723. PubMed ID: 32126320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics.
    Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Fernández FM; Edison AS
    J Proteome Res; 2021 Jul; 20(7):3629-3641. PubMed ID: 34161092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
    Zhang L; Li L; Kong H; Zeng F
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
    Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage.
    Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Edison AS; Fernández FM
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive model for recurrence of renal cell carcinoma by comparing pre- and postoperative urinary metabolite concentrations.
    Morozumi K; Kawasaki Y; Maekawa M; Takasaki S; Sato T; Shimada S; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
    Cancer Sci; 2022 Jan; 113(1):182-194. PubMed ID: 34710258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer.
    Yang M; Liu X; Tang X; Sun W; Ji Z
    Front Oncol; 2023; 13():1160965. PubMed ID: 37256175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS-based urine metabolomics analysis of chronic subdural hematoma for biomarker discovery.
    Sun J; Ou Y; Liu X; Sun H; Guo Z; Qi F; Lan Y; Liu W; Sun W
    Proteomics Clin Appl; 2024 Jan; 18(1):e2200107. PubMed ID: 37697649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-targeted metabolomics study for discovery of hepatocellular carcinoma serum diagnostic biomarker.
    Wang S; He T; Wang H
    J Pharm Biomed Anal; 2024 Feb; 239():115869. PubMed ID: 38064771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
    Xiong Y; Shi C; Zhong F; Liu X; Yang P
    Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
    Frantzi M; Metzger J; Banks RE; Husi H; Klein J; Dakna M; Mullen W; Cartledge JJ; Schanstra JP; Brand K; Kuczyk MA; Mischak H; Vlahou A; Theodorescu D; Merseburger AS
    J Proteomics; 2014 Feb; 98():44-58. PubMed ID: 24374379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.